Catalyst Wire Dossier Catalyst Wire Dossier

Fluticasone Furoate/GW642444 Inhalation Powder

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Fluticasone Furoate/GW642444 Inhalation Powder, covering 2013-08-19 to 2017-06-08. Get the full timeline:

Most recent: Clinical Trial Update: A Drug Interaction Study With Fluticasone Furoate/GW642444 Inhalation Powder and Ketoconazole [Phase 1]

See pricing